MRC RT01: an important trial

被引：3

作者：

Denham, James W. ^{[1
]}

机构：

[1] Univ Newcastle, Mater Hosp, Callaghan, NSW, Australia

来源：

LANCET ONCOLOGY | 2007年 / 8卷 / 06期

关键词：

LOCALIZED PROSTATE-CANCER; ANDROGEN DEPRIVATION; DOSE-RESPONSE; RADIOTHERAPY; THERAPY;

D O I：

10.1016/S1470-2045(07)70152-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：459 / 460

页数：2

共 10 条

[1] Delayed rectal and urinary symptomatotogy in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation [J].

Christie, D ;

Denham, J ;

Steigler, A ;

Lamb, D ;

Turner, S ;

Mameghan, H ;

Joseph, D ;

Matthews, J ;

Franklin, I ;

Atkinson, C ;

North, J ;

Poulsen, M ;

Spry, NA ;

Tai, KH ;

Wynne, C ;

Duchesne, G ;

Kovacev, O ;

Francis, L ;

Kramar, A ;

D'Este, C ;

Bill, D .

RADIOTHERAPY AND ONCOLOGY, 2005, 77 (02) :117-125

[2] Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials [J].

Collette, Laurence ;

Burzykowski, Tomasz ;

Schroder, Fritz H. .

EUROPEAN JOURNAL OF CANCER, 2006, 42 (10) :1344-1350

[3] Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial [J].

Dearnaley, David P. ;

Sydes, Matthew R. ;

Graham, John D. ;

Aird, Edwin G. ;

Bottomley, David ;

Cowan, Richard A. ;

Huddart, Robert A. ;

Jose, Chakiath C. ;

Matthews, John H. L. ;

Millar, Jeremy ;

Moore, A. Rollo ;

Morgan, Rachel C. ;

Russell, J. Martin ;

Scrase, Christopher D. ;

Stephens, Richard J. ;

Syndikus, Isabel ;

Parmar, Mahesh K. B. .

LANCET ONCOLOGY, 2007, 8 (06) :475-487

[4] Non-parametric methods for analysing recurrent complications of varying severity [J].

Lancar, R ;

Kramar, A ;

HaieMeder, C .

STATISTICS IN MEDICINE, 1995, 14 (24) :2701-2712

[5] Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy [J].

Peeters, STH ;

Heemsbergen, WD ;

Koper, PCM ;

van Putten, WLJ ;

Slot, A ;

Dielwart, MFH ;

Bonfrer, JMG ;

Incrocci, L ;

Lebesque, AV .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :1990-1996

[6] Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial [J].

Pollack, A ;

Zagars, GK ;

Starkschall, G ;

Antolak, JA ;

Lee, JJ ;

Huang, E ;

von Eschenbach, AC ;

Kuban, DA ;

Rosen, I .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05) :1097-1105

[7] Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference [J].

Roach, Mack, III ;

Hanks, Gerald ;

Thames, Howard, Jr. ;

Schellhammer, Paul ;

Shipley, William U. ;

Sokol, Gerald H. ;

Sandler, Howard .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04) :965-974

[8] Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European organisation for research and treatment of cancer (EORTC) trial 30891 [J].

Studer, UE ;

Whelan, P ;

Albrecht, W ;

Casselman, J ;

de Reijke, T ;

Hauri, D ;

Loidl, W ;

Isorna, S ;

Sundaram, SK ;

Debois, M ;

Collete, L .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) :1868-1876

[9] Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer [J].

Vicini, FA ;

Vargas, C ;

Abner, A ;

Kestin, L ;

Horwitz, E ;

Martinez, A .

JOURNAL OF UROLOGY, 2005, 173 (05) :1456-1462

[10] Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate - A randomized controlled trial [J].

Zietman, AL ;

DeSilvio, ML ;

Slater, JD ;

Rossi, CJ ;

Miller, DW ;

Adams, JA ;

Shipley, WU .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (10) :1233-1239

← 1 →